Acrivon Therapeutics (ACRV) vs OS Therapies (OSTX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Acrivon Therapeutics (ACRV) has outperformed OS Therapies (OSTX) over the past year, losing 1.6% versus a loss of 20.6%. Acrivon Therapeutics is the larger company by market cap ($80.1 million vs $75.8 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACRV | OSTX |
|---|---|---|
| Share price | $1.87 | $1.62 |
| Market cap | $80.14M | $75.82M |
| 1-day change | -0.53% | +4.52% |
| YTD return | -21.99% | +15.71% |
| 1-year return | -1.57% | -20.59% |
| Forward P/E | — | 4.67 |
| EPS (TTM) | $-1.88 | $-1.08 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.56 | $2.25 |
| 52-week low | $1.27 | $1.15 |
| Distance from 52-week high | -47.47% | -28.00% |
| Average volume | 361.40K | 597.09K |
| Shares outstanding | 42.85M | 46.81M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ACRV has outperformed OSTX by 19.0 percentage points over the past year.
ACRV vs OSTX FAQ
Which is bigger, Acrivon Therapeutics or OS Therapies?
Acrivon Therapeutics (ACRV) is larger, with a market capitalization of $80.14M compared with $75.82M for OS Therapies (OSTX).
Which stock has performed better over the past year, ACRV or OSTX?
ACRV returned -1.57% over the past 12 months, compared with -20.59% for OSTX (price return, excluding dividends). Past performance does not predict future results.
Are Acrivon Therapeutics and OS Therapies in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.